Global Real World Adelphi Real World offers disease-specific real-world evidence programs with multi-regional experience (Europe, USA, Asia, Latin America), presenting upsell opportunities in expanding market coverage and cross-border studies for multinational clients.

Lifecycle Evidence Their data spans the full compound lifecycle to inform Health Outcomes, Medical Affairs, Market Access and Marketing, suggesting potential upsell to clients seeking end-to-end evidence solutions from discovery through post-launch.

DSPs Advantage Disease Specific Programmes plus bespoke non-interventional studies position Adelphi as a specialist partner for sponsor pharmaceutical companies aiming to tailor evidence generation to specific indications and payer requirements.

Tech-Driven Utilizes a mix of analytics and database technologies (SAS/GRAPH, MySQL, SAP) which can be leveraged to enhance data sophistication, integration, and automation for larger pharma clients seeking advanced real-world evidence capabilities.

Mid-Mized Growth With revenue in the mid-range and a focused expert niche, Adelphi presents a scalable platform for growth through expanded client sponsorships, expanded programs, and potential cross-sell to large consulting ecosystems.